D. E. Shaw & Co. Inc. Increases Position in Enfusion, Inc. (NYSE:ENFN)

D. E. Shaw & Co. Inc. lifted its holdings in shares of Enfusion, Inc. (NYSE:ENFN) by 216.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 95,697 shares of the company’s stock after buying an additional 65,475 shares during the period. D. E. Shaw & Co. Inc. owned approximately 0.07% of Enfusion worth $986,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. KLP Kapitalforvaltning AS purchased a new stake in Enfusion during the 4th quarter valued at approximately $75,000. Dark Forest Capital Management LP purchased a new stake in shares of Enfusion during the fourth quarter worth approximately $128,000. Tower Research Capital LLC TRC raised its stake in shares of Enfusion by 58.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 13,227 shares of the company’s stock worth $136,000 after purchasing an additional 4,889 shares during the last quarter. Quantbot Technologies LP acquired a new position in Enfusion in the 4th quarter valued at $144,000. Finally, Aquatic Capital Management LLC raised its position in Enfusion by 2,013.2% during the 4th quarter. Aquatic Capital Management LLC now owns 15,828 shares of the company’s stock worth $163,000 after buying an additional 15,079 shares during the last quarter. Hedge funds and other institutional investors own 81.05% of the company’s stock.

Enfusion Stock Performance

ENFN stock opened at $10.85 on Friday. The stock has a market capitalization of $1.40 billion, a PE ratio of 271.29, a price-to-earnings-growth ratio of 1.85 and a beta of 0.92. The company has a fifty day moving average of $10.89 and a 200-day moving average of $10.74. Enfusion, Inc. has a one year low of $7.83 and a one year high of $11.80.

Enfusion (NYSE:ENFN) last posted its quarterly earnings results on Monday, March 3rd. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.02). The firm had revenue of $52.94 million for the quarter, compared to analysts’ expectations of $53.98 million. Enfusion had a return on equity of 6.67% and a net margin of 1.70%. Equities analysts forecast that Enfusion, Inc. will post 0.06 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, COO Neal Pawar sold 2,769 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total value of $31,788.12. Following the completion of the transaction, the chief operating officer now owns 1,231,627 shares in the company, valued at $14,139,077.96. This trade represents a 0.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Oleg Movchan sold 2,790 shares of Enfusion stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $11.48, for a total transaction of $32,029.20. Following the transaction, the chief executive officer now owns 643,299 shares of the company’s stock, valued at approximately $7,385,072.52. The trade was a 0.43% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 66,223 shares of company stock worth $754,778. Company insiders own 36.44% of the company’s stock.

Enfusion Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.